ALBERT

All Library Books, journals and Electronic Records Telegrafenberg

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Unknown
    Basel, Beijing, Wuhan : MDPI
    Keywords: chitosan ; alginate ; agar ; carrageenans ; exopolysaccharides ; chemical modification ; drug delivery ; gene delivery
    Description / Table of Contents: Biopolymers, as natural polysaccharides, are considered benign polymers for what concerns the environment. This is not a new invention, but at best a renaissance: the first type of polymers used by human kind were animal hides, cellulose, silk, wool. Among benefits of natural occurring biopolymers there are potential biocompatibility, renewable resources, low processing costs, tailoring of structure by genetic manipulation, and, as said, environmentally compatibility. Limits are, sometimes, premature degradation and high production costs due to the very high purity required for medical uses. Polysaccharides are not drugs by themselves, but their use in pharmaceutical field, for example as drug carriers or antimicrobial, anti-inflammatory or anticoagulant agents, is increasingly promising. Marine polysaccharides include chitin, chitosan, alginate, agar and carrageenans. Chitosan is a cationic carbohydrate biopolymer derived from chitin, the second most abundant polysaccharides present in nature after cellulose. The main sources of chitin are the shell wastes of shrimps, lobsters and crabs. For its characteristics, chitosan founds particular application as non viral vector in gene delivery. Films from chitosan are very tough and long lasting. Alginates derive from seaweed extraction (pheophyceae), and are mainly used in drug delivery and as hydrogels for immobilizing cells and enzymes, due to the mild conditions of cross-linking through bivalent cations (Ca2 ). Agar (or agar-agar) and carrageenans are linear polysaccharides from red seaweeds. They are highly reactive chemically and are peculiar for thermoreversible gel formation. Exopolysaccharides (EPS), substantial components of the extracellular matrix of many cells of marine origin, also have to be mentioned for their potential interest in pharmaceuticals, and new EPS producing bacteria, particularly from extreme marine environments, are being isolated.The possibility of chemical modification, blending and addition of biodegradable additives allows to tailor the final properties of polysaccharides and opens the doors to wider applications, particularly in pharmaceutical area. This issue is intended to explore any new potentiality of marine polysaccharides, as those above mentioned, deriving from chemical or chemical-physical modifications, and the scaling-up of their pharmaceutical applications.
    Pages: Online-Ressource (X, 564 Seiten)
    Edition: Printed Edition of the Special Issue Published in Marine Drugs
    ISBN: 9783038429029
    Language: English
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 2
    Unknown
    Basel, Beijing, Wuhan : MDPI
    Keywords: chitosan ; alginate ; agar ; carrageenans ; exopolysaccharides ; chemical modification ; drug delivery ; gene delivery
    Description / Table of Contents: Biopolymers, as natural polysaccharides, are considered benign polymers for what concerns the environment. This is not a new invention, but at best a renaissance: the first type of polymers used by human kind were animal hides, cellulose, silk, wool. Among benefits of natural occurring biopolymers there are potential biocompatibility, renewable resources, low processing costs, tailoring of structure by genetic manipulation, and, as said, environmentally compatibility. Limits are, sometimes, premature degradation and high production costs due to the very high purity required for medical uses. Polysaccharides are not drugs by themselves, but their use in pharmaceutical field, for example as drug carriers or antimicrobial, anti-inflammatory or anticoagulant agents, is increasingly promising. Marine polysaccharides include chitin, chitosan, alginate, agar and carrageenans. Chitosan is a cationic carbohydrate biopolymer derived from chitin, the second most abundant polysaccharides present in nature after cellulose. The main sources of chitin are the shell wastes of shrimps, lobsters and crabs. For its characteristics, chitosan founds particular application as non viral vector in gene delivery. Films from chitosan are very tough and long lasting. Alginates derive from seaweed extraction (pheophyceae), and are mainly used in drug delivery and as hydrogels for immobilizing cells and enzymes, due to the mild conditions of cross-linking through bivalent cations (Ca2+). Agar (or agar-agar) and carrageenans are linear polysaccharides from red seaweeds. They are highly reactive chemically and are peculiar for thermoreversible gel formation. Exopolysaccharides (EPS), substantial components of the extracellular matrix of many cells of marine origin, also have to be mentioned for their potential interest in pharmaceuticals, and new EPS producing bacteria, particularly from extreme marine environments, are being isolated. The possibility of chemical modification, blending and addition of biodegradable additives allows to tailor the final properties of polysaccharides and opens the doors to wider applications, particularly in pharmaceutical area. This issue is intended to explore any new potentiality of marine polysaccharides, as those above mentioned, deriving from chemical or chemical-physical modifications, and the scaling-up of their pharmaceutical applications.
    Pages: Online-Ressource (VIII, 224 Seiten)
    Edition: Printed Edition of the Special Issue Published in Marine Drugs
    ISBN: 9783038428985
    Language: English
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 3
    Unknown
    Basel, Beijing, Wuhan : MDPI
    Keywords: chitosan ; alginate ; agar ; carrageenans ; exopolysaccharides ; chemical modification ; drug delivery ; gene delivery
    Description / Table of Contents: Biopolymers, as natural polysaccharides, are considered benign polymers for what concerns the environment. This is not a new invention, but at best a renaissance: the first type of polymers used by human kind were animal hides, cellulose, silk, wool. Among benefits of natural occurring biopolymers there are potential biocompatibility, renewable resources, low processing costs, tailoring of structure by genetic manipulation, and, as said, environmentally compatibility. Limits are, sometimes, premature degradation and high production costs due to the very high purity required for medical uses. Polysaccharides are not drugs by themselves, but their use in pharmaceutical field, for example as drug carriers or antimicrobial, anti-inflammatory or anticoagulant agents, is increasingly promising. Marine polysaccharides include chitin, chitosan, alginate, agar and carrageenans. Chitosan is a cationic carbohydrate biopolymer derived from chitin, the second most abundant polysaccharides present in nature after cellulose. The main sources of chitin are the shell wastes of shrimps, lobsters and crabs. For its characteristics, chitosan founds particular application as non viral vector in gene delivery. Films from chitosan are very tough and long lasting. Alginates derive from seaweed extraction (pheophyceae), and are mainly used in drug delivery and as hydrogels for immobilizing cells and enzymes, due to the mild conditions of cross-linking through bivalent cations (Ca2 ). Agar (or agar-agar) and carrageenans are linear polysaccharides from red seaweeds. They are highly reactive chemically and are peculiar for thermoreversible gel formation. Exopolysaccharides (EPS), substantial components of the extracellular matrix of many cells of marine origin, also have to be mentioned for their potential interest in pharmaceuticals, and new EPS producing bacteria, particularly from extreme marine environments, are being isolated.The possibility of chemical modification, blending and addition of biodegradable additives allows to tailor the final properties of polysaccharides and opens the doors to wider applications, particularly in pharmaceutical area. This issue is intended to explore any new potentiality of marine polysaccharides, as those above mentioned, deriving from chemical or chemical-physical modifications, and the scaling-up of their pharmaceutical applications.
    Pages: Online-Ressource (X, 290 Seiten)
    Edition: Printed Edition of the Special Issue Published in Marine Drugs
    ISBN: 9783038429005
    Language: English
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 4
    Publication Date: 2019-09-20
    Description: Nanoparticles (NPs) based on amphiphilic block copolymers of polyethylene glycol (PEG) and biodegradable polyesters are of particular current interest in drug nanodelivery due to their easily manipulated properties. The interaction of these NPs with biological environments is highly influenced by shell features, which drive biological identity after administration. To widen the strategies available for tuning particle surface chemistry, here we developed a panel of amine-bearing PEGylated NPs with a poly(ε-caprolactone) (PCL) core for the delivery of lipophilic drugs, and investigated the impact of NP modifications on their interaction with abundant circulating proteins (human serum albumin—HSA—and mucin), as well as their transport through biological barriers (artificial mucus—AM, extracellular matrix—ECM). We prepared NPs based on a diamino-terminated PCL (amine-NPs) and its mixture with PEG-PCL copolymers (amine/PEG-NPs) at different PEG molecular weights by nanoprecipitation, as well as corresponding NPs of PEG-PCL (PEG-NPs). The presence of an amine-bearing polymer resulted in NPs with a net positive charge and a zeta potential dependent on the length of PEG in the copolymer. Amine/PEG-NPs had a larger fixed aqueous layer thickness as compared to PEG-NPs, suggesting that PEG conformation is affected by the presence of positive charges. In general, amine-bearing NPs promptly interacted with the dysopsonic protein HSA, due to electrostatic interactions, and lose stability, thereby undergoing time-related aggregation. On the other hand, amine/PEG-NPs interaction with mucin induced switching to a negative surface charge but did not alter the quality of the dispersion. The transport kinetics of NPs through a layer of artificial mucus and tumor extracellular matrix was studied by means of fluorescent NPs based upon FRET. Amine/PEG-NPs did not cross the ECM, but they were promptly transported through the AM, with swifter transport noted at increasing MWs of PEG in the copolymer. Finally, we demonstrated that all the different NP types developed in this study are internalized by human monocytes and, despite the positive charge, they did not induce a measurable inflammatory effect. In conclusion, we showed that the concurrent presence of both PEG and amine groups on NP surface is a promising strategy for directing their interaction with body compartments. While PEG-NPs are confirmed for their capacity to cross ECM-like compartments, amine/PEG-NPs are revealed as a powerful platform to widen the arsenal of nanotools available for overcoming mucus-covered epithelia.
    Electronic ISSN: 2079-4991
    Topics: Physics
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 5
    Publication Date: 2015-05-11
    Electronic ISSN: 1660-3397
    Topics: Chemistry and Pharmacology
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...